104 related articles for article (PubMed ID: 9616774)
1. Whole-body hyperthermia and ADPRT inhibition in experimental treatment of brain tumors.
Salford LG; Brun A; Kjellén E; Pero RW; Persson RB
Ann N Y Acad Sci; 1997 Dec; 835():194-202. PubMed ID: 9616774
[TBL] [Abstract][Full Text] [Related]
2. Poly(ADP-ribosyl)ation enhancement in brain cell nuclei is associated with diabetic neuropathy.
Kuchmerovska T; Shymanskyy I; Donchenko G; Kuchmerovskyy M; Pakirbaieva L; Klimenko A
J Diabetes Complications; 2004; 18(4):198-204. PubMed ID: 15207836
[TBL] [Abstract][Full Text] [Related]
3. Poly(ADP-ribose) synthesis in blocked and damaged cells and its relation to carcinogenesis.
Boulikas T
Anticancer Res; 1992; 12(3):885-98. PubMed ID: 1535771
[TBL] [Abstract][Full Text] [Related]
4. Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.
Wang ZQ; Auer B; Stingl L; Berghammer H; Haidacher D; Schweiger M; Wagner EF
Genes Dev; 1995 Mar; 9(5):509-20. PubMed ID: 7698643
[TBL] [Abstract][Full Text] [Related]
5. Effects of hyperthermia and nicotinamide on DNA repair synthesis, ADP-ribosyl transferase activity, NAD+ and ATP pools, and cytotoxicity in gamma-irradiated human mononuclear leukocytes.
Kjellén E; Jonsson GG; Pero RW; Christensson PI
Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Jan; 49(1):151-62. PubMed ID: 3000966
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic efficacy of long duration-low temperature whole body hyperthermia when combined with tumor necrosis factor and carboplatin in rats.
Sakaguchi Y; Makino M; Kaneko T; Stephens LC; Strebel FR; Danhauser LL; Jenkins GN; Bull JM
Cancer Res; 1994 Apr; 54(8):2223-7. PubMed ID: 8174130
[TBL] [Abstract][Full Text] [Related]
7. Maturation of human promyelocytic leukemia cells induced by nicotinamide: evidence of a regulatory role for ADP-ribosylation of chromosomal proteins.
Lucas DL; Tanuma S; Davies PJ; Wright DG; Johnson GS
J Cell Physiol; 1984 Nov; 121(2):334-40. PubMed ID: 6149227
[TBL] [Abstract][Full Text] [Related]
8. Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
Ohno S; Siddik ZH; Baba H; Stephens LC; Strebel FR; Wondergem J; Khokhar AR; Bull JM
Cancer Res; 1991 Jun; 51(11):2994-3000. PubMed ID: 2032236
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy and apoptosis and necrosis kinetics of doxorubicin compared with cisplatin, combined with whole-body hyperthermia in a rat mammary adenocarcinoma.
Toyota N; Strebel FR; Stephens LC; Matsuda H; Oshiro T; Jenkins GN; Bull JM
Int J Cancer; 1998 May; 76(4):499-505. PubMed ID: 9590125
[TBL] [Abstract][Full Text] [Related]
10. Tumor oxygenation under combined whole-body-hyperthermia and polychemotherapy in a case of recurrent carcinoma of the oral cavity.
Sagowski C; Jaehne M; Kehrl W; Hegewisch-Becker S; Wenzel S; Panse J; Nierhaus A
Eur Arch Otorhinolaryngol; 2002 Jan; 259(1):27-31. PubMed ID: 11954922
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of ADP-ribosyl transferase suppress the mitogenic actions exerted by tumour promoters, but not those evoked by peptide mitogens, in primary neonatal rat hepatocytes.
Romano F; Menapace L; Armato U
Carcinogenesis; 1988 Dec; 9(12):2147-54. PubMed ID: 2973375
[TBL] [Abstract][Full Text] [Related]
12. The effect of whole-body hyperthermia combined with 'metronomic' chemotherapy on rat mammary adenocarcinoma metastases.
Sumiyoshi K; Strebel FR; Rowe RW; Bull JM
Int J Hyperthermia; 2003; 19(2):103-18. PubMed ID: 12623634
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect of whole body hyperthermia with alpha-galactosylceramide in a subcutaneous tumor model of colon cancer.
Hattori T; Kokura S; Okuda T; Okayama T; Takagi T; Handa O; Naito Y; Yoshida N; Yoshikawa T
Int J Hyperthermia; 2007 Nov; 23(7):591-8. PubMed ID: 18038289
[TBL] [Abstract][Full Text] [Related]
14. Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
Baba H; Siddik ZH; Strebel FR; Jenkins GN; Bull JM
Cancer Res; 1989 Dec; 49(24 Pt 1):7041-4. PubMed ID: 2582445
[TBL] [Abstract][Full Text] [Related]
15. Mitogenic induction of ornithine decarboxylase in human mononuclear leukocytes: relationships with adenosine diphosphate ribosyltransferase.
Johnson DB; Markowitz MM; Joseph PE; Miller DG; Pero RW
Int J Biochem; 1990; 22(1):67-73. PubMed ID: 2139420
[TBL] [Abstract][Full Text] [Related]
16. PJ-34 inhibits PARP-1 expression and ERK phosphorylation in glioma-conditioned brain microvascular endothelial cells.
Motta C; D'Angeli F; Scalia M; Satriano C; Barbagallo D; Naletova I; Anfuso CD; Lupo G; Spina-Purrello V
Eur J Pharmacol; 2015 Aug; 761():55-64. PubMed ID: 25934569
[TBL] [Abstract][Full Text] [Related]
17. The RG2 rat glioma model.
Aas AT; Brun A; Blennow C; Strömblad S; Salford LG
J Neurooncol; 1995; 23(3):175-83. PubMed ID: 7673979
[TBL] [Abstract][Full Text] [Related]
18. Poly(ADP-ribosyl)ation and stroke.
Chiarugi A
Pharmacol Res; 2005 Jul; 52(1):15-24. PubMed ID: 15911330
[TBL] [Abstract][Full Text] [Related]
19. Whole body hyperthermia supplemented with urotropin in the treatment of malignant tumors.
Ismail-Zade RS
Exp Oncol; 2005 Mar; 27(1):61-4. PubMed ID: 15812360
[TBL] [Abstract][Full Text] [Related]
20. ADP-ribosylation, DNA repair, cell differentiation and cancer.
Shall S
Princess Takamatsu Symp; 1983; 13():3-25. PubMed ID: 6317641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
